5-HT4 receptor modulation of acetylcholine outflow in guinea pig brain slices

NeuroReport

Volumn 10, Issue 3, 1999, Pages 547-551

  Siniscalchi, Anna ^a   Badini, Irene ^a   Beani, Lorenzo ^a   Bianchi, Clementina ^a  

^a UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 3 ISOPROPYL 2 OXO 1 BENZIMIDAZOLECARBOXYLIC ACID 3ALPHA TROPANYLAMIDE; 5 FLUORO 2 METHOXY 1H INDOLE 3 CARBOXYLIC ACID 1 [2 (METHYLSULFONAMIDO)ETHYL] 4 PIPERIDINYLMETHYL ESTER; ACETYLCHOLINE; CHOLINE; POTASSIUM CHLORIDE; SEROTONIN 4 AGONIST; SEROTONIN 4 ANTAGONIST; SEROTONIN 4 RECEPTOR; TRITIUM; (ENDO N 8 METHYL 8 AZABICYCLO (3.2.1)OCT 3 YL) 2,3 DIHYDRO 3 ISOPROPYL 2 OXO 1H BENZIMIDAZOL 1 CARBOXAMIDE; (ENDO-N-8-METHYL-8-AZABICYCLO-(3.2.1)OCT-3-YL)-2,3-DIHYDRO-3-ISOPROPYL-2-OXO-1H-BENZIMIDAZOL-1-CARBOXAMIDE; BENZIMIDAZOLE DERIVATIVE; FUSED HETEROCYCLIC RINGS; SEROTONIN RECEPTOR;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; ELECTROSTIMULATION; FEMALE; GIANT CELL; GUINEA PIG; HIPPOCAMPUS; MALE; NEUROCHEMISTRY; NONHUMAN; OLIVARY NUCLEUS; PRIORITY JOURNAL; SYNAPTOSOME; ANIMAL; BRAIN; DRUG EFFECT; ELECTROPHYSIOLOGY; IN VITRO STUDY; METABOLISM; PHYSIOLOGY;

ACETYLCHOLINE; ANIMALS; BENZIMIDAZOLES; BICYCLO COMPOUNDS, HETEROCYCLIC; BRAIN; CHOLINE; ELECTRIC STIMULATION; ELECTROPHYSIOLOGY; FEMALE; GUINEA PIGS; HIPPOCAMPUS; MALE; POTASSIUM CHLORIDE; RECEPTORS, SEROTONIN; SYNAPTOSOMES;

EID: 0033601866     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199902250-00019     Document Type: Article

References (25)

1. 1. Dumuis A, Bouheal R, Sebben M et al. Mol Pharmacol 34, 880-887 (1988).
2. 2. Bockaert J, Sebben M and Dumuis M. Mol Pharmacol 37, 408-411 (1989).
3. 3. Eglen RM, Wong EHF, Dumuis M et al. Trends Pharmacol Sci 16, 391-398 (1995).
4. 4. Torres R, Chaput Y and Andrade R. Mol Pharmacol 47, 191-197 (1995).
5. 5. Steward LJ, Ge J, Stowe RL et al. Br J Pharmacol 117, 55-62 (1996).
6. 6. Kilbinger H and Wolf D. Naunyn-Schmiedeberg's Arch Pharmacol 345, 270-275 (1992).
7. 7. Consolo S, Arnaboldi S, Giorgi S et al. Neuroreports, 5, 1230-1232 (1994).
8. 8. WongEHF, Gavin P, Reynolds GP et al. Behav Res 73, 249-252 (1996).
9. 9. Beani L, Blanchi C, Giacomelli A et al. Eur J Pharmacol 48, 179-193 (1978).
10. 10. Siniscalchi A, Badini I, Bianchi C et al. Naunyn-Schmiedeberg's Arch Pharmacol 350, 10-14 (1994).
11. 11. Simonato M, Bregola G, Muzzolini A et al. Neurochem Int 23, 555-560 (1993).
12. 12. Beani L, Bianchi C, Siniscalchi A et al. Naunyn-Schmiedeberg's Arch Pharmacol 328, 119-129 (1984).
13. 13. Tallarida RJ and Murray RB. Manual of Pharmacological Calculation with Computer Programs, New York: Springer-Verlag, 1986.
14. 14. Bianchi C, Siniscalchi A and Beani L. Br J Pharmacol 97, 213-221 (1989).
15. 15. Ansanay H, Sebben M, Bockaert J et al. Mol Pharmacol 42, 808-816 (1992).
16. 16. Adham N, Gerald C, Vayesse PJ et al. Br J Pharmacol 114, 158P (1995).
17. 17. Bianchi C, Siniscalchi A and Beani L. Neuropharmacol 25, 1043-1049 (1986).
18. 18. Rondé P, Ansanay H, Dumuis A et al. J Pharmacol Exp Ther 272, 977-983 (1995).
19. 19. Yamaguchi T, Suzuki M and Yamamoto M. Brain Res 772, 95-101 (1997).
20. 20. Wonnacot S. Trends Neurosci 29, 92-98, 1997.
21. 21. Cassel JC and Jeltsch H. Neuroscience 69, 1-45 (1995).
22. 22. Buhot MC. Curr Opin Neurobiol 7, 243-254 (1997).
23. 23. Hochner B and Kandel E. Proc Natl Acad Sci USA 89, 11476-11480 (1992).
24. 24. Marchotti-Gouthier E, Roman FS, Dumuis A et al. Neuropharmacology 36. 697-706 (1997).
25. 25. Fontana DJ, Daniels SE, Wong EH et al. Neuropharmacology 36, 689-696 (1997).